This is where things stand now. Proposed rule and public comment
What If You Need Human Pharmacokinetic Data for Protocol Design
Vendors that cannot document their supply chain where the bacteriostatic water comes from, who manufactured it, what testing was performed represent the same documentation gap as unverified marketplace sources
its someone who allows themselves to be defined by what they do, not what they feel
Preclinical evidence supports synergistic effects on soft tissue repair when both peptides are studied together
found that efficacy was consistent across mRNA, DNA, viral vectors, and inactive viruses and that differences in trial design, population characteristics and other factors were stronger contributors to heterogeneity than vaccine modality